[Federal Register Volume 68, Number 139 (Monday, July 21, 2003)]
[Notices]
[Page 43164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18477]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated March 21, 2003 and published in the Federal 
Register on April 9, 2003, (68 FR 17403), Boehringer Ingelheim 
Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as an importer of Phenylacetone (8501), a basic 
class of controlled substances listed in Schedule II.
    The firm plans to import Phenylacetone for bulk manufacture of 
amphetamine.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Boehringer Ingelheim Chemicals, 
Inc. to import the listed controlled substances is consistent with the 
public interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. on a 
regular basis to ensure that the company's continued registration is 
consistent with the public interest. This investigation included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to section 1008(a) of the Controlled Substances Import and Export Act 
and in accordance with Title 21, Code of Federal Regulations, section 
1301.34, the above firm is granted registration as an importer of the 
basic classes of controlled substances listed above.

    Dated: July 2, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-18477 Filed 7-18-03; 8:45 am]
BILLING CODE 4410-09-M